Clinical Trial Update: Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

This Phase 2 trial assesses the effectiveness of fludarabine plus octreotide in patients with relapsed low-grade Non-Hodgkin lymphoma. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Fludarabine (Fludarabine)
• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lymphoma | Phase 2 | Status: COMPLETED